Table 4 Three-year survival rates in patients treated with or without concurrent chemotherapy
No concurrent chemotherapy | With concurrent chemotherapy | P Value | |
|---|---|---|---|
MFS | 85.8% | 84.5% | 0.65 |
DFS | 80.3% | 82.6% | 0.48 |
OS | 89.2% | 89.1% | 0.82 |
No concurrent chemotherapy | With concurrent chemotherapy | P Value | |
|---|---|---|---|
MFS | 85.8% | 84.5% | 0.65 |
DFS | 80.3% | 82.6% | 0.48 |
OS | 89.2% | 89.1% | 0.82 |